SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,174.65 |
| Enterprise Value ($M) | 1,090.05 |
| Book Value ($M) | 586.00 |
| Book Value / Share | 8.53 |
| Price / Book | 2.00 |
| NCAV ($M) | 568.40 |
| NCAV / Share | 8.27 |
| Price / NCAV | 2.07 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.24 |
| Return on Equity (ROE) | -0.47 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.17 |
| Current Ratio | 4.17 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,149.50 |
| Assets | 1,167.10 |
| Liabilities | 581.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Citadel Advisors Llc | |||
| 13G/A | Price T Rowe Associates Inc /md/ | 5.60 | 0.48 | |
| 13G/A | Rtw Investments, Lp | 4.10 | -33.97 | |
| 13G/A | BlackRock, Inc. | 9.50 | 0.00 | |
| 13G/A | Vanguard Group Inc | 10.26 | 45.19 | |
| 13G/A | EcoR1 Capital, LLC | 9.99 | 117.73 | |
| 13G/A | Avidity Partners Management LP | 4.40 | -39.69 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 292,686 | 924,149 | 31.67 | |
| 213,237 | 735,865 | 28.98 | |
| 126,830 | 544,559 | 23.29 | |
| 165,858 | 596,190 | 27.82 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ANNX – Annexon, Inc. | APLS – Apellis Pharmaceuticals, Inc. |
| ARQT – Arcutis Biotherapeutics, Inc. | ARWR – Arrowhead Pharmaceuticals, Inc. |
| ASMB – Assembly Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io